Table 1 Sample demographics and scores in experimental variables
| Â | Male sample | Female sample | ||||
|---|---|---|---|---|---|---|
|  | Diagnosed (n = 108) | Suspected ED (n = 90) | Total (n = 198) | Diagnosed (n = 155) | Suspected ED (n = 110) | Total (n = 265) |
Age | 30.11 (9.4), 18–55 | 32.26 (10.36), 18–58 | 31.09 (9.9), 18–58 | 29.97 (9.3), 2–59 | 28.79 (10.15), 18–69 | 29.48 (9.6), 18–69 |
AQ-Short total | 74.03 (11.3), 46–107 | 71.98 (11.22), 46–100 | 73.10 (11.3), 46–107 | 70.06 (13.4), 38–106 | 67.98 (10.76), 43–95 | 69.20 (12.4), 38–106 |
Percentage over cut-off (> 65) | 78.81 | 73.33 | 78.88 | 58.97 | 60 | 59.40 |
TAS-20 total | 64.28 (11.1), 29–85 | 60.31 (12.51), 28–84 | 62.47 (11.9), 28–85 | 61.34 (12.5), 28–88 | 58.76 (12.41), 34–83 | 60.27 (12.5), 28–88 |
Percentage over cut-off (> 61) | 63.30 | 51.11 | 57.78 | 50.64 | 43.64 | 47.74 |
EDEQ total | 3.75 (1.1), 1.32 | 3.29 (1.32), .27–6 | 3.54 (1.21), .27–6 | 4.19 (1.1), .68–6 | 3.93 (1.15), .73–5.8 | 4.08 (1.1), .68–6 |
DASS total score | 68.67 (24.1), 6–120 | 64.27 (22.06), 14–124 | 66.67 (23.3), 6–124 | 66.00 (24.0), 14–120 | 61.51 (25.67), 10–126 | 64.1 (24.7), 10–126 |
Percentage over cut-off (> 16) | 99.08 | 98.88 | 98.99 | 98.08 | 94.55 | 96.62 |